Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemigliptin/Metformin FDC PK Study in Healthy Volunteers
NCT02670018Phase 1Unknown
- Sponsor
- LG Chem
- Start
- Aug 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of gemigliptin in type 2 diabetes mellitus (T2DM), sponsored by LG Chem. Primary endpoint: Area under the plasma concentration-time curve from time zero to the last measurable concentration at 48 hours. Status: unknown.
02
Drugs
gemigliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02670018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02670018.